Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why Naked-Short Selling Accusations May Not Help GameStop Stock Bulls

By Josh Enomoto, InvestorPlace Contributor

Although enthusiasm about a naked short squeeze is strong for GME stock, you may want to reconsider this thesis.

Is Ocugen Worth a Shot Because of the Worsening Pandemic?

By Josh Enomoto, InvestorPlace Contributor

While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.

Zomedica Stock Might Not Appeal To Millennials as Much as Some Hope

By Josh Enomoto, InvestorPlace Contributor

While the U.S. pet market is theoretically conducive for ZOM stock, you should consider the fine print before jumping onboard.

An Unbalanced Business Could Hurt SoFi Technologies

By Josh Enomoto, InvestorPlace Contributor

Although SOFI stock is undergirded by several relevant financial solutions, warranted skepticism clouds its bullish narrative.

Don’t Pin Your Hopes for Sundial on U.S. Legalization

By Josh Enomoto, InvestorPlace Contributor

No matter what you think about SNDL stock, it’s best to assume that U.S. cannabis laws will stay as is.

Load More